Authors: STALDER N SUDRE P OLMARI M OPRAVIL M GABRIEL V SANSONETTI A VONOVERBECK J HERBORT CP HIRSCHEL B BATTEGAY M BURGISSER P JEANNEROD L EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P

Citation: N. Stalder et al., CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT, Clinical infectious diseases, 24(4), 1997, pp. 620-624

Authors: KAISER L PERRIN L HIRSCHEL B FURRER H VONOVERBECK J OLMARI M YERLY S

Citation: L. Kaiser et al., FOSCARNET DECREASES HUMAN-IMMUNODEFICIENCY-VIRUS RNA, The Journal of infectious diseases, 172(1), 1995, pp. 225-227

Authors: CHEVALLEY GF OLMARI M BONVIN ER DOSSO AA SANSONETTI A HIRSCHEL B LEUENBERGER PM

Citation: Gf. Chevalley et al., STUDY OF KERATIC PRECIPITATES ASSOCIATED WITH CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Klinische Monatsblatter fur Augenheilkunde, 204(5), 1994, pp. 348-349